GLP-1 Medications Fuel Growth in Medical Aesthetics, with Weight Loss Accounting for 11% of Non-Surgical Spending in 2024
NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) — Guidepoint Qsight, a leader in leveraging proprietary data to provide unmatched analytics solutions, today revealed new insights on the state of the $17.5 billion Medical Aesthetics industry,… Read More »GLP-1 Medications Fuel Growth in Medical Aesthetics, with Weight Loss Accounting for 11% of Non-Surgical Spending in 2024



